The Magazine for Sleep Professionals
Friday, May 15, 2026
As the coronavirus pandemic enters its second year, stress and anxiety are leaving many American adults struggling to get sufficient, quality sleep. Some may be tempted to turn to supplements like melatonin, but the American Academy of Sleep Medicine advises caution. Melatonin is a natural hormone that helps regulate the daily […]
Ebb has merged with Kryo®, the parent company of sleep technology brand ChiliSleep® to become a market leader in innovative sleep products and technologies. At a time when millions of Americans are struggling with sleep, the combined business brings together two complementary suites of products to help you take better […]
A study found a significant increase in the number of online search queries for “insomnia” between April and May 2020, when governments across the U.S. and around the world implemented stay-at-home orders in response to the COVID-19 pandemic. Results show there were 2.77 million Google searches for insomnia in the […]
Pear Therapeutics, Inc., announced the availability of Somryst™, the first prescription digital therapeutic (PDT) intended for use in the treatment of patients 22 years of age and older with chronic insomnia. Somryst addresses the underlying issues of chronic insomnia by delivering cognitive behavioral therapy for insomnia (CBTi), an evidence-based approach […]
With growing interest in its potential health benefits and new legislation favoring legalization in more states, cannabis use is becoming more common among older adults. University of California San Diego School of Medicine researchers report that older adults use cannabis primarily for medical purposes to treat a variety of common […]
Weighted blankets are a safe and effective intervention in the treatment of insomnia, according to Swedish researchers who found that insomnia patients with psychiatric disorders experienced reduced insomnia severity, improved sleep, and less daytime sleepiness when sleeping with a weighted chain blanket. Results of the randomized, controlled study show that participants using […]
SleepScore Labs, the Sleep Science Company behind the world’s most comprehensive suite of data-backed sleep solutions, has announced its partnership with Ebb Therapeutics® and has added the wearable CoolDrift™ sleep device to its assortment of scientifically-validated products. The Ebb CoolDrift technology tackles the pervasive issue of sleeplessness, offering a solution to help […]
June features the shortest nights of the year, but for those living with chronic insomnia, every night is long. That’s why the American Academy of Sleep Medicine (AASM), Society of Behavioral Sleep Medicine (SBSM) and American Alliance for Healthy Sleep (AAHS) are working to raise awareness of the disease with Insomnia Awareness Night […]
Merck has announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for an update to the prescribing information for BELSOMRA® (suvorexant) C-IV to include findings on its use for the treatment of insomnia in patients with mild-to-moderate Alzheimer’s disease. BELSOMRA is indicated for the treatment […]
Approval Based on Robust Clinical Development Program That Included Two Pivotal Trials of Nearly 2,000 Patients Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced the U.S. Food and Drug Administration (FDA) approved DAYVIGOTM (lemborexant) 5 mg and 10 mg for the treatment of adult patients with insomnia, characterized […]
